Ph.D in Pharmaceutics / Industrial Pharmacy with 02 years of experience in Academic / Industry Research / product design and development with at least one research paper in SCI journal. NIPER
Bachelor degree in Pharma with 50% marks from a recognized University/ Board or equivalent along with at least 02 years’ experience in level 2 in the related Held in a University/ Govt. Delhi Pharmaceutical Sciences and Research University
Ph.D. in Management from premier business schools and first class or equivalent grade in MBA (Pharm.) or MBA or M.Com. with marketing as specialization with a very good academic records throughout. NIPER SAS Nagar
M. Sc. (Physics/ Chemistry/ Electronics), M. Pharma, B.E. / B. Tech (Instrumentation/Electronics Engg (Materials Science/ Materials Engineering, or related subjects) with consistent excellent academic record. Amity University
Besides fulfilling the above qualifications, the candidate must have cleared the National Eligibility Test (NET) conducted by the UGC or the CSIR, or a similar test accredited by the UGC, like SLET/SET or who are or have been awarded a Ph. D. Degree in accordance with ihe University Grants Commission
Masters degree in Biotechnology / Microbiology / Botany / Life sciences or related areas. OR B. Tech / BS or equivalent degree in any other relevant quantitative fields.
Candidates holding a Masters degree (with at least 55% marks) in in Natural Sciences / Agriculture / Life sciences / Plant biology / Botany are eligible to apply.
Applications are invited from suitable candidates for the following position at National Institute of Animal Biotechnology (NIAB), Hyderabad, against a DBT-funded project.
Support global regulatory lifecycle management activities across EU, US, and international markets. Contribute to regulatory strategy development for global and regional submissions
With a humble beginning in the year 1984 as a wholesale Pharma distributors in Gujarat, had started Sunrise Laboratories as an Ayurvedic Finished Product formulation in the year 1988, Sunrise become a Sunrise Remedies Pvt. Ltd. in 1996. What it is today; the seeds of it were implanted by Mr. Jaman Malaviya and Mr. Abhishek Malaviya when they started Pharmaceutical Manufacturing of various Allopathic, Ayurvedic medicines and cosmetics products.
Biophore has announced that it has entered into a definitive agreement with Par Health to acquire an FDA-approved sterile injectable manufacturing facility in Indore, India.
MSN has announced the successful launch of its Teduglutide Injection across several key European markets, marking a significant milestone in the company’s development of complex peptide medicines.
The launch is based on the dossier developed by MSN following the first generic approval for Teduglutide in Europe. According to the company, the achievement also makes MSN the first company to secure approval for a generic Teduglutide dossier in a G7 nation.